Table
of Contents
|
|
|
|
About the Authors |
2 |
|
Preface |
3 |
|
Introduction |
4 |
|
White
Lesions |
15 |
|
Red Lesions |
37 |
|
Ulcerated
Lesions |
53 |
|
Blistering/Sloughing
Lesions |
79 |
|
Pigmented
Lesions |
93 |
|
Papillary
Lesions |
105 |
|
Soft tissue
Enlargements |
115 |
|
Drug section |
|
|
Alphabetical Listing
of Drugs Commonly Used in the Treatment of Oral Soft Tissue Diseases |
145 |
|
Example Prescriptions |
163 |
|
Special
Topics |
|
|
Management of
Patients Undergoing Cancer Therapy |
178 |
|
Oral Lesions in
Cancer Treatment |
179 |
|
Dry Mouth (Xerostomia) |
180 |
|
Artificial Saliva
Products |
180 |
|
Other Dry Mouth
Products |
181 |
|
Saliva Substitute
(Rx Only) |
181 |
|
Cholinergic Salivary
Stimulants (Rx Only) |
181 |
|
Fluorides |
182 |
|
Prescription Only
Products |
182 |
|
Over-The-Counter
Products |
182 |
|
Osteonecrosis of the Jaw and Bisphosphonate-Associated
Osteonecrosis
of the Jaw |
183 |
|
Antibiotic Prophylaxis- Preprocedural
Guidelines for Dental Patients |
184 |
|
HIV Infection and AIDS |
188 |
|
Natural History of
HIV Infection/Oral Manifestations |
188 |
|
CD4+ Lymphocyte Count
and Percentage as Related to the Risk of Opportunistic Infections |
188 |
|
Oral Lesions
Commonly Seen in HIV/AIDS |
188 |
|
Normal Blood Values |
189 |
|
Suggested |
190 |
|
Anatomic
Site Index |
197 |
|
Alphabetical
Index |
207 |
|
|
|